Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia

Methods in Molecular Biology

Volumn 999, Issue , 2013, Pages 1-23

  Moore, Franklin R ^a   Rempfer, Carole B ^b   Press, Richard D ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

BCR ABL1; Chronic myelogenous leukemia; Imatinib; Major molecular response; Philadelphia chromosome

Indexed keywords

IMATINIB; RNA;

ARTICLE; BCR ABL1 GENE; BLOOD CELL; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CYTOLYSIS; GENE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 84883255822     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-357-2_1     Document Type: Article

References (15)

1. Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F et al (2006) Evolving concepts in the management of chronic myeloid leukemia. Recommendations from an expert panel on behalf of the European Leukemianet. Blood 108:1809-1820
2. O'Hare T, Eide CA, Deininger MW (2007) Bcr-Abl kinase domain mutations, drug resistance and the road to a cure of chronic myeloid leukemia. Blood 110:2242-2249
3. Radich JP (2001) Philadelphia chromosomepositive acute lymphocytic leukemia. Hematol Oncol Clin North Am 15:21-36
4. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al (2001) Ef fi cacy and safety of a speci fi c inhibitor of the BCRABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037
5. Hughes TP, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley ML et al (2003) Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med 349:1423-1432
6. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N et al (2006) Five-Year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355:2408-2417
7. Press RD, Galderisi C, Yang R, Rempfer C, Willis SG, Mauro MJ et al (2007) A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with CML with an imatinib-induced complete cytogenetic response (CCR). Clin Cancer Res 13:6136-6143
8. Press RD, Willis SG, Laudadio J, Mauro MJ, Deininger MW (2009) Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib. Blood 114:2598-2605
9. Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929-1936
10. Press RD, Love Z, Tronnes AA, Yang R, Tran T, Mongoue-Tchokote S et al (2006) BCRABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib-Treated patients with CML. Blood 107:4250-4256
11. Branford S, Fletcher L, Cross NC, Muller MC, Hochhaus A, Kim DW et al (2008) Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood 112: 3330-3338
12. Hughes TP, Deininger MW, Hochhaus A, Branford S, Radich JP, Kaeda J et al (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors-Review and recommendations for 'harmonizing' current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108:28-37
13. White H, Matejtschuk P, Rigsby P, Gabert J, Lin F, Wang L et al (2010) Establishment of the fi rst World Health Organization international genetic reference panel for quantitation of BCR-ABL mRNA. Blood 116: E111-e117
14. Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A et al (1999) Accurate and rapid analysis of residual disease in patients with CML using speci fi c fl uorescent hybridization probes for real time quantitative RT-PCR. Leukemia 13:1825-1832
15. Westgard JO, Barry PL, Hunt MR, Groth T (1981) A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 27:493-501